BWP
WST icon

Baldwin Wealth Partners’s West Pharmaceutical WST Stock Holding History

Baldwin Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,353
Closed -$406K – 1047
2024
Q3 		$406K Buy
1,353
+1,346
+19,229% +$412K 0.03% 228
2024
Q2 		$2.31K Hold
7
– – ﹤0.01% 649
2024
Q1 		$2.77K Hold
7
– – ﹤0.01% 634
2023
Q4 		$2.46K Hold
7
– – ﹤0.01% 660
2023
Q3 		$2.63K Hold
7
– – ﹤0.01% 672
2023
Q2 		$2.68K Hold
7
– – ﹤0.01% 684
2023
Q1 		$2.42K Hold
7
– – ﹤0.01% 719
2022
Q4 		$1.65K Buy
+7
New +$1.66K ﹤0.01% 721

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Baldwin Wealth Partners's WST Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 1,353 shares — an estimated $406K sold.

Baldwin Wealth Partners first reported a position in WST in Q4 2022 and held it in 8 quarters. The position peaked at $406K in Q3 2024. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 1,353 West Pharmaceutical shares in Q4 2024, an estimated $406K.
  • Baldwin Wealth Partners first reported a position in West Pharmaceutical in Q4 2022 and held it in 8 quarters.
  • Baldwin Wealth Partners's West Pharmaceutical position peaked at $406K in Q3 2024.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.